0001140361-18-014330.txt : 20180320
0001140361-18-014330.hdr.sgml : 20180320
20180320172751
ACCESSION NUMBER: 0001140361-18-014330
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180316
FILED AS OF DATE: 20180320
DATE AS OF CHANGE: 20180320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Li Yvonne
CENTRAL INDEX KEY: 0001735045
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35993
FILM NUMBER: 18702701
MAIL ADDRESS:
STREET 1: C/O ONCOMED PHARMACEUTICALS, INC.
STREET 2: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001302573
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383572512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-995-8200
MAIL ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
3
1
doc1.xml
FORM 3
X0206
3
2018-03-16
0
0001302573
OncoMed Pharmaceuticals Inc
OMED
0001735045
Li Yvonne
C/O ONCOMED PHARMACEUTICALS, INC.
800 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
See Remarks
Common Stock
64952
D
Stock Option (Right to Buy)
3.42
2018-12-04
Common Stock
1017
D
Stock Option (Right to Buy)
8.55
2023-03-14
Common Stock
15571
D
Stock Option (Right to Buy)
17
2023-07-16
Common Stock
5000
D
Stock Option (Right to Buy)
21.18
2024-12-17
Common Stock
35000
D
Stock Option (Right to Buy)
21.43
2025-12-26
Common Stock
30000
D
Stock Option (Right to Buy)
7.66
2027-01-02
Common Stock
45000
D
Stock Option (Right to Buy)
3.73
2027-04-22
Common Stock
50000
D
Stock Option (Right to Buy)
4.36
2027-10-06
Common Stock
26666
D
Stock Option (Right to Buy)
3.98
2028-01-03
Common Stock
55000
D
Includes 45,834 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
The option is fully vested and exercisable.
The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of December 18, 2014, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of December 27, 2015, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of January 3, 2017, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 23, 2017, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of October 7, 2017, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of January 4, 2018, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Vice President, Finance, Controller and Administration
/s/ Alicia J. Hager, Attorney-in-Fact for Yvonne Li
2018-03-20